Conestoga Capital Advisors LLC purchased a new position in Cognex Corporation (NASDAQ:CGNX – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 179,060 shares of the scientific and technical instruments company’s stock, valued at approximately $10,860,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Chicago Partners Investment Group LLC increased its position in Cognex by 12.4% in the third quarter. Chicago Partners Investment Group LLC now owns 18,857 shares of the scientific and technical instruments company’s stock worth $1,048,000 after buying an additional 2,078 shares during the period. Provenance Wealth Advisors LLC acquired a new position in shares of Cognex during the third quarter valued at $300,000. Oregon Public Employees Retirement Fund boosted its holdings in shares of Cognex by 1.2% during the third quarter. Oregon Public Employees Retirement Fund now owns 34,809 shares of the scientific and technical instruments company’s stock valued at $2,111,000 after acquiring an additional 400 shares during the period. Bridge City Capital LLC boosted its holdings in shares of Cognex by 21.5% during the third quarter. Bridge City Capital LLC now owns 60,742 shares of the scientific and technical instruments company’s stock valued at $3,684,000 after acquiring an additional 10,760 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its position in shares of Cognex by 0.5% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,227,288 shares of the scientific and technical instruments company’s stock worth $135,085,000 after acquiring an additional 11,927 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.
Cognex Price Performance
Shares of NASDAQ:CGNX opened at $53.06 on Thursday. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88. The stock has a market cap of $8.93 billion, a price-to-earnings ratio of 51.52 and a beta of 1.49. The stock’s 50 day moving average price is $59.65 and its 200 day moving average price is $57.96.
Cognex (NASDAQ:CGNX – Get Free Report) last released its earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.01. The firm had revenue of $313.39 million during the quarter, compared to the consensus estimate of $313.62 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%. The firm’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.33 earnings per share. On average, sell-side analysts expect that Cognex Corporation will post 1.68 EPS for the current year.
Cognex Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 3rd. Investors of record on Thursday, November 19th will be issued a dividend of $0.09 per share. The ex-dividend date of this dividend is Thursday, November 19th. This is an increase from Cognex’s previous quarterly dividend of $0.0850. This represents a $0.36 dividend on an annualized basis and a yield of 0.7%. Cognex’s dividend payout ratio is presently 33.01%.
Analyst Ratings Changes
A number of research firms recently weighed in on CGNX. Truist Financial set a $74.00 price objective on shares of Cognex and gave the stock a “hold” rating in a report on Monday, October 5th. HSBC lowered shares of Cognex from a “buy” rating to a “hold” rating and set a $65.00 target price for the company. in a research note on Monday, August 10th. Needham & Company LLC restated a “buy” rating and issued a $80.00 target price on shares of Cognex in a research report on Tuesday, September 15th. Weiss Ratings upgraded shares of Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, Cantor Fitzgerald raised their price target on shares of Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cognex presently has an average rating of “Moderate Buy” and an average target price of $75.57.
View Our Latest Research Report on Cognex
Key Stories Impacting Cognex
Here are the key news stories impacting Cognex this week:
- Positive Sentiment: Q3 adjusted EPS was $0.53, above estimates of about $0.51–$0.52 and up from $0.33 a year earlier. Revenue increased 13% year over year to $313.39 million, and the company raised its 2026 guidance after a record quarter. Cognex Reports Third Quarter 2026 Results Cognex Fiscal Q3 Adjusted Earnings, Revenue Increase; 2026 Guidance Raised
- Positive Sentiment: Cognex raised its quarterly dividend 5.9%, from $0.085 to $0.09 per share, equivalent to $0.36 annually and a 0.7% yield. Cognex dividend announcement
- Neutral Sentiment: One valuation article argued CGNX could be 33% undervalued; this is an opinion rather than a company announcement or guaranteed catalyst. Cognex Could Be 33% Undervalued Following Record Q3 and Raised Outlook
- Negative Sentiment: Revenue came in just below consensus ($313.39 million versus $313.62 million). Although EPS beat estimates, the small revenue miss and reports of a post-results stock decline suggest investors may have expected a stronger surprise. Cognex Q3 2026 Results and Stock Reaction
Cognex Company Profile
Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.
The company’s product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.
Featured Articles
- Five stocks we like better than Cognex
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
